Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
Autori:
Scheubeck G, Jiang L, Hermine O, Kluin-Nelemans HC, Schmidt C, Unterhalt M, Rosenwald A, Klapper W, Evangelista A, Ladetto M, Jerkeman M, Ferrero S, Dreyling M, Hoster E.
Rivista:
Leukemia 2023; 37: 1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26. PMID: 37495776 (IF 11.4)